B

Biodyne Co Ltd
KOSDAQ:314930

Watchlist Manager
Biodyne Co Ltd
KOSDAQ:314930
Watchlist
Price: 15 780 KRW -1.8%
Market Cap: 465.1B KRW
Have any thoughts about
Biodyne Co Ltd?
Write Note

Gross Margin
Biodyne Co Ltd

22%
Current
36%
Average
47.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
22%
=
Gross Profit
921.1m
/
Revenue
4.2B

Gross Margin Across Competitors

No Stocks Found

Biodyne Co Ltd
Glance View

Market Cap
465.1B KRW
Industry
Health Care

Biodyne Co., Ltd. engages in the development of cancer diagnosis solutions. The company is headquartered in Seoul, Seoul and currently employs 26 full-time employees. The company went IPO on 2021-03-17. The firm produces and sells LBC diagnostic equipment and diagnostic reagent kits. The firm's LBC equipment include PATHPLORER AUTO, PATHPLORER 4.7, PATHPLORER 4.63 and PATHPLORER ECO. The firm sells its products in domestic and overseas markets such as Japan, Russia, Portugal and Thailand.

Intrinsic Value
482.17 KRW
Overvaluation 97%
Intrinsic Value
Price
B
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
22%
=
Gross Profit
921.1m
/
Revenue
4.2B
What is the Gross Margin of Biodyne Co Ltd?

Based on Biodyne Co Ltd's most recent financial statements, the company has Gross Margin of 22%.

Back to Top